TY - JOUR
T1 - Crystal structure of an anti-podoplanin antibody bound to a disialylated O-linked glycopeptide
AU - Ogasawara, Satoshi
AU - Suzuki, Kano
AU - Naruchi, Kentaro
AU - Nakamura, Seiwa
AU - Shimabukuro, Junpei
AU - Tsukahara, Nanase
AU - Kaneko, Mika K.
AU - Kato, Yukinari
AU - Murata, Takeshi
N1 - Funding Information:
This research was supported in part by Japan Agency for Medical Research and Development (AMED) under Grant nos. JP20am0101083 (T.M.), JP20am0101078 (Y·K.), JP20am0401013 (Y·K.) and JP20ae0101028 (Y·K.), and by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) under Grant nos. 18H05425 (T.M.), 17K07299 (M.K·K.), and 19K07705 (Y·K.).
Publisher Copyright:
© 2020 The Authors
PY - 2020/11/26
Y1 - 2020/11/26
N2 - Podoplanin (PDPN) is a highly O-glycosylated glycoprotein that is utilized as a specific lymphatic endothelial marker under pathophysiological conditions. We previously developed an anti-human PDPN (hPDPN) monoclonal antibody (mAb), clone LpMab-3, which recognizes the epitope, including both the peptides and the attached disialy-core-l (NeuAcα2-3Galβl-3 [NeuAcα2-6]GalNAcαl-O-Thr) structure at the Thr76 residue in hPDPN. However, it is unclear if the mAb binds directly to both the peptides and glycans. In this study, we synthesized the binding epitope region of LpMab-3 that includes the peptide (-67LVATSVNSV-T-GIRIEDLP84-) possessing a disialyl-core-1 O-glycan at Thr76, and we determined the crystal structure of the LpMab-3 Fab fragment that was bound to the synthesized glycopeptide at a 2.8 Å resolution. The six amino acid residues and two sialic acid residues are directly associated with four complementarity-determining regions (CDRs; H1, H2, H3, and L3) and four CDRs (H2, H3, L1, and L3), respectively. These results suggest that IgG is advantageous for generating binders against spacious epitopes such as glycoconjugates.
AB - Podoplanin (PDPN) is a highly O-glycosylated glycoprotein that is utilized as a specific lymphatic endothelial marker under pathophysiological conditions. We previously developed an anti-human PDPN (hPDPN) monoclonal antibody (mAb), clone LpMab-3, which recognizes the epitope, including both the peptides and the attached disialy-core-l (NeuAcα2-3Galβl-3 [NeuAcα2-6]GalNAcαl-O-Thr) structure at the Thr76 residue in hPDPN. However, it is unclear if the mAb binds directly to both the peptides and glycans. In this study, we synthesized the binding epitope region of LpMab-3 that includes the peptide (-67LVATSVNSV-T-GIRIEDLP84-) possessing a disialyl-core-1 O-glycan at Thr76, and we determined the crystal structure of the LpMab-3 Fab fragment that was bound to the synthesized glycopeptide at a 2.8 Å resolution. The six amino acid residues and two sialic acid residues are directly associated with four complementarity-determining regions (CDRs; H1, H2, H3, and L3) and four CDRs (H2, H3, L1, and L3), respectively. These results suggest that IgG is advantageous for generating binders against spacious epitopes such as glycoconjugates.
KW - Crystal structure
KW - Glycopeptide
KW - Monoclonal antibody
KW - Podoplanin (PDPN)
UR - http://www.scopus.com/inward/record.url?scp=85090482821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090482821&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2020.08.103
DO - 10.1016/j.bbrc.2020.08.103
M3 - Article
C2 - 32921414
AN - SCOPUS:85090482821
SN - 0006-291X
VL - 533
SP - 57
EP - 63
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -